Statements (39)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:cancer
|
| gptkbp:affects |
breast tissue
|
| gptkbp:canMetastasizeTo |
gptkb:meninges
gastrointestinal tract ovaries peritoneum |
| gptkbp:cellType |
small, uniform cells
|
| gptkbp:commonIn |
postmenopausal women
|
| gptkbp:diagnosedBy |
MRI
biopsy mammography |
| gptkbp:firstDescribed |
1941
|
| gptkbp:frequency |
accounts for 10-15% of breast cancers
|
| gptkbp:histology |
single-file cell pattern
|
| https://www.w3.org/2000/01/rdf-schema#label |
lobular breast cancer
|
| gptkbp:ICD-10_code |
C50
|
| gptkbp:lessLikelyToExpress |
gptkb:HER2/neu
|
| gptkbp:lessLikelyToForm |
palpable mass
|
| gptkbp:lessLikelyToShow |
microcalcifications on mammogram
|
| gptkbp:marking |
loss of E-cadherin expression
|
| gptkbp:mayExpress |
estrogen receptor
progesterone receptor |
| gptkbp:originatedIn |
lobules of the breast
|
| gptkbp:prognosis |
generally similar to ductal breast cancer
|
| gptkbp:riskFactor |
hormone replacement therapy
family history of breast cancer increasing age |
| gptkbp:subspecies |
gptkb:invasive_lobular_carcinoma
lobular carcinoma in situ |
| gptkbp:symptom |
breast swelling
breast thickening change in breast texture |
| gptkbp:treatment |
surgery
radiation therapy chemotherapy hormone therapy targeted therapy |
| gptkbp:bfsParent |
gptkb:E-cadherin
|
| gptkbp:bfsLayer |
6
|